Toll Free: 1-888-928-9744

China, Russia, Brazil and Japan Drugs for Treatment of Prostate Cancer Research Report 2015 to 2021

Published: Jun 14, 2016 | Pages: 152 | Publisher: QYResearch | Industry: Pharmaceutical | Report Format: Electronic (PDF)

The global Drugs for Treatment of Prostate Cancer market was valued at USD 30.41 Billion in 2015, and is projected to reach USD 35.26 Billion by 2021, at a CAGR of 59.49% between 2016 and 2021. The market is projected witness significant growth in the coming years, owing to the aging population increase, increased incidence and development of new drugs

This report studies Drugs for Treatment of Prostate Cancer in China, Russia, Brazil and Japan market, including Triptorelin, Leuprorelin, Flutamide Tablets, Goserelin, Bicalutamide Tablets, Bicalutamide Capsules, Estramustine Phosphate Capsules, Mitoxantrone, Zytiga and Xtandi, focuses on price, sales, revenue of each type in global. This report also focuses on the sales (consumption), production, import and export of Drugs for Treatment of Prostate Cancer forecast to 2021, from 2015.
 
On basis of segments by Types, this report focuses on price, sales, revenue and growth rate of each type, as well as the types and each type price of key manufacturers, through interviewing key manufacturers.

On basis of segments by manufacturers, this report focuses on the sales, price of each type, average price of Drugs for Treatment of Prostate Cancer, revenue and market share, for key manufacturers. The main manufacturers as follows: IPSEN, Ferring Pharmaceuticals, Takeda Pharmaceutical Company Limited, Schering-Plough Canada, S.C.SINDAN-PHARMA S.R.L., AstraZeneca, Corden Pharma GmbH, Shanxi Zhendong Pharmaceutical, Pfizer, Johnson, Astellas and so on.

On basis of segments by regions, this report focuses on the sales (consumption), production, import and export of Drugs for Treatment of Prostate Cancer in America, Established ROW, Western Europe, Emerging Markets, Russia and China.

On basis of segments by applications, this report focuses on consumption and growth rate of Drugs for Treatment of Prostate Cancer in major applications.

With 220ges, 231 charts and eight chapters, to display the market present situation and future, clearly and deeply.

 
 Table of Contents
China, Russia, Brazil and Japan Drugs for Treatment of Prostate Cancer Research Report 2015 to 2021 1 Drugs for Treatment of Prostate Cancer Overview and Each Type 1.1 Product Overview of Prostate Cancer 1.1.1 Definition and Product Scope of Drugs for Prostate Cancer 1.1.2 China Market Size (Value and Volume) of Drugs for Prostate Cancer 2016-2021 1.1.3 Russia Market Size (Value and Volume) of Drugs for Prostate Cancer 2016-2021 1.1.4 Brazil Market Size (Value and Volume) of Drugs for Prostate Cancer 2016-2021 1.1.5 Japan Market Size (Value and Volume) of Drugs for Prostate Cancer 2016-2021 1.2 Product Segments and Price of Each Type 1.2.1 Product Type of Key Manufacturers 1.2.2 Price List and of Each Type 2015 to 2016 1.2.3 Market Share and Growth Rate of Each Type 1.2.4 Triptorelin and Specification 1.2.5 Leuprorelin and Specification 1.2.6 Flutamide Tablets and Specification 1.2.7 Goserelin and Specification 1.2.8 Bicalutamide Tablets and Specification 1.2.9 Bicalutamide Capsules and Specification 1.2.10 Estramustine Phosphate Capsules and Specification 1.2.11 Mitoxantrone and Specification 1.2.12 Zytiga and Specification 1.2.13 Xtandi and Specification 1.3 Price List (Interviewed) of Each Type for Manufacturers 2015 and 2016 1.3.1 Price List (Interviewed) of Triptorelin by Manufacturers 1.3.2 Price List (Interviewed) of Leuprorelin by Key Manufacturers 1.3.3 Price List (Interviewed) of Flutamide Tablets by Manufacturers 1.3.4 Price List (Interviewed) of Goserelin by Manufacturers 1.3.5 Price List (Interviewed) of Bicalutamide Tablets by Manufacturers 1.3.6 Price List (Interviewed) of Bicalutamide Capsules by Manufacturers 1.3.7 Price List (Interviewed) of Estramustine Phosphate Capsules by Manufacturers 1.3.8 Price List (Interviewed) of Mitoxantrone by Manufacturers 1.3.9 Price List (Interviewed) of Zytiga by Manufacturers 1.3.10 Price List (Interviewed) of Xtandi by Manufacturers 2 Competition Analysis by Manufacturers in Global and China 2.1 Market Drugs for Treatment of Prostate Cancer Sales and Share List of Key Manufacturers 2015 to 2016 2.2 China Market Drugs for Treatment of Prostate Cancer Sales and Share List of Key Manufacturers 2010 to 2015 2.3 China Market Drugs for Treatment of Prostate Cancer Revenue and Share List of Key Manufacturers 2010 to 2015 2.4 China Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 2016 2.5 Russia Market Drugs for Treatment of Prostate Cancer Sales and Share List of Key Manufacturers 2010 to 2015 2.6 Russia Market Drugs for Treatment of Prostate Cancer Revenue and Share List of Key Manufacturers 2010 to 2015 2.7 Russia Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 2016 2.8 Brazil Market Drugs for Treatment of Prostate Cancer Sales and Share List of Key Manufacturers 2010 to 2015 2.9 Brazil Market Drugs for Treatment of Prostate Cancer Revenue and Share List of Key Manufacturers 2010 to 2015 2.10 Brazil Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 2016 2.11 Japan Market Drugs for Treatment of Prostate Cancer Sales and Share List of Key Manufacturers 2010 to 2015 2.12 Japan Market Drugs for Treatment of Prostate Cancer Revenue and Share List of Key Manufacturers 2010 to 2015 2.13 Japan Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 2016 3 Sales and Revenue Segments of Each Type 2010 to 2015 3.1 China Sales and Revenue Segments of Each Type 2010 to 2015 3.1.1 China Sales and Market Share of Each Type 2010 to 2015 3.1.2 China Sales Growth Rate of Each Type 2015 to 2016 3.1.3 China Revenue and Market Share of Each Type 2015 to 2016 3.1.4 China Revenue and Market Share of Each Type 2015 to 2016 3.2 Russia Sales and Revenue Segments of Each Type 2015 to 2016 3.2.1 Russia Sales and Market Share of Each Type 2015 to 2016 3.2.2 Russia Sales Growth Rate of Each Type 2015 to 2016 3.2.3 Russia Revenue and Market Share of Each Type 2015 to 2016 3.2.4 Russia Revenue and Market Share of Each Type 2015 to 2016 3.3 Brazil Sales and Revenue Segments of Each Type 2015 to 2016 3.3.1 Brazil Sales and Market Share of Each Type 2015 to 2016 3.3.2 Brazil Sales Growth Rate of Each Type 2015 to 2016 3.3.3 Brazil Revenue and Market Share of Each Type 2015 to 2016 3.3.4 Brazil Revenue and Market Share of Each Type 2015 to 2016 3.4 Japan Sales and Revenue Segments of Each Type 2015 to 2016 3.3.1 Japan Sales and Market Share of Each Type 2015 to 2016 3.3.2 Japan Sales Growth Rate of Each Type 2015 to 2016 3.3.3 Japan Revenue and Market Share of Each Type 2015 to 2016 3.3.4 Japan Revenue and Market Share of Each Type 2015 to 2016 4 Market Segments and Forecast of Drugs for Treatment of Prostate Cancer by Regions 4.1 Sales (Consumption) and Forecast of Drugs for Treatment of Prostate Cancer by Regions 2016-2021 4.1.1 Sales and Forecast of Drugs for Treatment of Prostate Cancer by Regions 2016-2021 4.1.2 Sales Growth Rate Forecast of Drugs for Treatment of Prostate Cancer by Regions 2016 to 2021 5 Raw Materials and Applications 5.1 Key Raw Materials and Price Analysis for Triptorelin 5.1.1 Key Raw Materials for Triptorelin 5.1.2 Price Forecast of Key Raw Materials for Triptorelin 2016 to 2021 5.2 Key Raw Materials and Price Analysis for Leuprorelin 5.2.1 Key Raw Materials for Leuprorelin 5.2.2 Price Forecast of Key Raw Materials for Leuprorelin 2016 to 2021 5.3 Key Raw Materials and Price Analysis for Flutamide Tablets 5.3.1 Key Raw Materials for Flutamide Tablets 5.3.2 Price Forecast of Key Raw Materials for Flutamide Tablets 2016 to 2021 5.4 Key Raw Materials and Price Analysis for Goserelin 5.4.1 Key Raw Materials for Goserelin 5.4.2 Price Forecast of Key Raw Materials for Goserelin 2016 to 2021 5.5 Key Raw Materials and Price Analysis for Bicalutamide Tablets 5.5.1 Key Raw Materials for Bicalutamide Tablets 5.5.2 Price Forecast of Key Raw Materials for Bicalutamide Tablets 2016 to 2021 5.6 Key Raw Materials and Price Analysis for Bicalutamide Capsules 5.6.1 Key Raw Materials for Bicalutamide Capsules 5.6.2 Price Forecast of Key Raw Materials for Bicalutamide Capsules 2016 to 2021 5.7 Key Raw Materials and Price Analysis for Estramustine Phosphate Capsules 5.7.1 Key Raw Materials for Estramustine Phosphate Capsules 5.7.2 Price Forecast of Key Raw Materials for Estramustine Phosphate Capsules 2016 to 2021 5.8 Key Raw Materials and Price Analysis for Mitoxantrone 5.8.1 Key Raw Materials for Mitoxantrone 5.8.2 Price Forecast of Key Raw Materials for Mitoxantrone 2016 to 2021 5.9 Key Raw Materials and Price Analysis for Zytiga 5.9.1 Key Raw Materials for Zytiga 5.9.2 Price Forecast of Key Raw Materials for Zytiga 2016 to 2021 5.10 Key Raw Materials and Price Analysis for Xtandi 5.10.1 Key Raw Materials for Xtandi 5.10.2 Price Forecast of Key Raw Materials for Xtandi 2016 to 2021 5.11 Applications of Triptorelin 5.12 Applications of Leuprorelin 5.13 Applications of Flutamide Tablets 5.14 Applications of Goserelin 5.15 Applications of Bicalutamide Tablets 5.16 Applications of Bicalutamide Capsules 5.17 Applications of Estramustine Phosphate Capsules 5.18 Applications of Mitoxantrone 5.19 Applications of Zytiga 5.20 Applications of Xtandi 6 Key Manufacturers Analysis of Drugs for Treatment of Prostate Cancer 6.1 IPSEN 6.1.1 IPSEN Basic Information 6.2.2 Triptorelin (Specification and Price) 6.2.3 Sales Value, Gross Margin 2011-2016 6.1.4 Interviewee, Name and Contact 6.2 Ferring Pharmaceuticals 6.2.1 Company Basic Information 6.2.2 Triptorelin (Specification and Price) 6.2.3 Sales Value, Gross Margin 2011-2016 6.2.4 Interviewee, Name and Contact 6.3 Chengdu Tiantaishan pharmaceutical 6.3.1 Company Basic Information 6.3.2 Triptorelin (Specification and Price) 6.3.3 Sales Value, Gross Margin 2011-2016 6.3.4 Interviewee, Name and Contact 6.4 GeneScience Pharmaceuticals 6.4.1 Company Basic Information 6.4.2 Triptorelin (Specification and Price) 6.4.3 Sales Value, Gross Margin 2011-2016 6.4.4 Interviewee, Name and Contact 6.5 Takeda Pharmaceutical Company Limited 6.5.1 Company Basic Information 6.5.2 Leuprorelin (Specification and Price) 6.5.3 Sales Value, Gross Margin 2011-2016 6.5.4 Interviewee, Name and Contact 6.6 Beijing Biote Pharmaceutical 6.6.1 Company Basic Information 6.6.2 Leuprorelin (Specification and Price) 6.6.3 Sales Value, Gross Margin 2011-2016 6.6.4 Interviewee, Name and Contact 6.7 Livzon Pharmaceutical Group 6.7.1 Company Basic Information 6.7.2 Leuprorelin (Specification and Price) 6.7.3 Sales Value, Gross Margin 2011-2016 6.7.4 Interviewee, Name and Contact 6.8 Schering-Plough Canada 6.8.1 Company Basic Information 6.8.2 Flutamide Tablets (Specification and Price) 6.8.3 Sales Value, Gross Margin 2011-2016 6.8.3 Sales Value, Gross Margin 2011-2016 6.8.3 Sales Value, Gross Margin 2011-2016 6.8.3 Sales Value, Gross Margin 2011-2016 6.8.4 Interviewee, Name and Contact 6. 9 JiangSu TASLY DI YI Pharmaceutical 6.9.1 Company Basic Information 6.9.2 Flutamide Tablets (Specification and Price) 6.9.3 Sales Value, Gross Margin 2011-2016 6.9.4 Interviewee, Name and Contact 6.10 Shanghai Fudan Fuhua Pharmaceutical 6.10.1 Company Basic Information 6.10.2 Flutamide Tablets (Specification and Price) 6.10.3 Sales Value, Gross Margin 2011-2016 6.10.4 Interviewee, Name and Contact 6.11 S.C.SINDAN-PHARMA S.R.L. 6.11.1 Company Basic Information 6.11.2 Flutamide Tablets (Specification and Price) 6.11.3 Sales Value, Gross Margin 2011-2016 6.11.4 Interviewee, Name and Contact 6.12 AstraZeneca 6.12.1 Company Basic Information 6.12.2 Goserelin (Specification and Price) 6.12.3 Sales Value, Gross Margin 2011-2016 6.12.4 Interviewee, Name and Contact 6.13 Corden Pharma GmbH 6.13.1 Company Basic Information 6.13.2 Bicalutamide Tablets (Specification and Price) 6.13.3 Sales Value, Gross Margin 2011-2016 6.13.4 Interviewee, Name and Contact 6.14 Shanghai Zhaohui Pharmaceutical 6.14.1 Company Basic Information 6.14.2 Bicalutamide Tablets (Specification and Price) 6.14.3 Sales Value, Gross Margin 2011-2016 6.14.4 Interviewee, Name and Contact 6.15 HISUN Pharmaceutical 6.15.1 Company Basic Information 6.15.2 Bicalutamide Tablets (Specification and Price) 6.15.3 Sales Value, Gross Margin 2011-2016 6.15.4 Interviewee, Name and Contact 6.16 Shanxi Zhendong Pharmaceutical 6.16.1 Company Basic Information 6.16.2 Bicalutamide Capsules (Specification and Price) 6.16.3 Sales Value, Gross Margin 2011-2016 6.16.4 Interviewee, Name and Contact 6.17 Pfizer 6.17.1 Company Basic Information 6.17.2 Estramustine Phosphate Capsules (Specification and Price) 6.17.3 Sales Value, Gross Margin 2011-2016 6.17.4 Interviewee, Name and Contact 6.18 Sichuan sunnyhope pharmaceutical 6.18.1 Company Basic Information 6.18.2 Mitoxantrone (Specification and Price) 6.18.3 Sales Value, Gross Margin 2011-2016 6.18.4 Interviewee, Name and Contact 6.19 Luoxin Group 6.19.1 Company Basic Information 6.19.2 Mitoxantrone (Specification and Price) 6.19.3 Sales Value, Gross Margin 2011-2016 6.19.4 Interviewee, Name and Contact 6.20 Jiangsu Aosaikang Pharmaceutical 6.20.1 Company Basic Information 6.20.2 Mitoxantrone (Specification and Price) 6.20.3 Sales Value, Gross Margin 2011-2016 6.20.4 Interviewee, Name and Contact 6.21 JIANG SU HENG RUI MEDICINE 6.21.1 Company Basic Information 6.21.2 Mitoxantrone (Specification and Price) 6.21.3 Sales Value, Gross Margin 2011-2016 6.21.4 Interviewee, Name and Contact 6.22 Johnson 6.22.1 Company Basic Information 6.22.2 Zytiga (Specification and Price) 6.22.3 Sales Value, Gross Margin 2011-2016 6.22.4 Interviewee, Name and Contact 6.23 Astellas 6.23.1 Company Basic Information 6.23.2 Xtandi (Specification and Price) 6.23.3 Sales Value, Gross Margin 2011-2016 6.23.4 Interviewee, Name and Contact 7 Technology Development Trend 7.1 Manufacturing Process of Drugs for Treatment of Prostate Cancer 7.2 Analysis of Manufacturing Process 7.3 Development Trend 8 Research Findings and Conclusion
List of Tables and Figures
Figure Picture of Drugs for Prostate Cancer 17 Figure China Market Size (Value) of Drugs for Prostate Cancer 2016-2021 17 Figure China Market Size (Volume) of Drugs for Prostate Cancer 2016-2021 17 Figure Russia Market Size (Value) of Drugs for Prostate Cancer 2016-2021 17 Figure Russia Market Size (Volume) of Drugs for Prostate Cancer 2016-2021 18 Figure Brazil Market Size (Value) of Drugs for Prostate Cancer 2016-2021 18 Figure Brazil Market Size (Volume) of Drugs for Prostate Cancer 2016-2021 18 Figure Japan Market Size (Value) of Drugs for Prostate Cancer 2016-2021 18 Figure Japan Market Size (Volume) of Drugs for Prostate Cancer 2016-2021 18 Table Product Type of Key Manufacturers 18 Table Price List and Forecast of Each Type 19 Table Market Share of Each Type 19 Figure Growth Rate of Each Type 2014 to 2015 20 Figure Picture of Triptorelin 20 Table Specification of Triptorelin 20 Figure Picture of Leuprorelin 20 Table Specification of Leuprorelin 20 Figure Picture of Flutamide Tablets 21 Table Specification of Flutamide Tablets 21 Figure Picture of Goserelin 21 Table Specification of Goserelin 21 Figure Picture of Bicalutamide Tablets 21 Table Specification of Bicalutamide Tablets 21 Figure Picture of Type Bicalutamide Capsules 21 Table Specification of Type Bicalutamide Capsules 21 Figure Picture of Estramustine Phosphate Capsules 22 Table Specification of Estramustine Phosphate Capsules 22 Figure Picture of Mitoxantrone 22 Table Specification of Mitoxantrone 22 Figure Picture of Zytiga 22 Table Specification of Zytiga 22 Figure Picture of Xtandi 22 Table Specification of Xtandi 23 Table Price List (Interviewed) of Triptorelin by Manufacturers 2015 and 2016 23 Table Price List (Interviewed) of Leuprorelin by Manufacturers 2015 and 2016 23 Table Price List (Interviewed) of Flutamide Tablets by Manufacturers 2015 and 2016 24 Table Price List (Interviewed) of Flutamide Tablets by Manufacturers 2015 and 2016 24 Table Price List (Interviewed) of Bicalutamide Tablets by Manufacturers 2015 and 2016 25 Table Price List (Interviewed) of Bicalutamide Capsules by Manufacturers 2015 and 2016 25 Table Price List (Interviewed) of Estramustine Phosphate Capsules by Manufacturers 2015 and 2016 26 Table Price List (Interviewed) of Estramustine Phosphate Capsules by Manufacturers 2015 and 2016 26 Table Price List (Interviewed) of Zytiga Phosphate Capsules by Manufacturers 2015 and 2016 27 Table Price List (Interviewed) of Xtandi Phosphate Capsules by Manufacturers 2015 and 2016 27 Table Global Market Drugs for Treatment of Prostate Cancer Sales List of Key Manufacturers 2015 to 2016 28 Table Global Market Drugs for Treatment of Prostate Cancer Sales Share List of Key Manufacturers 2015 to 2016 28 Table China Market Drugs for Treatment of Prostate Cancer Sales List of Key Manufacturers 2010 to 2015 29 Table China Market Drugs for Treatment of Prostate Cancer Sales Share List of Key Manufacturers 2010 to 2015 29 Table China Market Drugs for Treatment of Prostate Cancer Revenue List of Key Manufacturers 2010 to 2015 30 Table China Market Drugs for Treatment of Prostate Cancer Revenue Share List of Key Manufacturers 2010 to 2015 30 Table China Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 2016 31 Table Russia Market Drugs for Treatment of Prostate Cancer Sales List of Key Manufacturers 2010 to 2015 32 Table Russia Market Drugs for Treatment of Prostate Cancer Sales Share List of Key Manufacturers 2010 to 2015 32 Table Russia Market Drugs for Treatment of Prostate Cancer Revenue List of Key Manufacturers 2010 to 2015 33 Table Russia Market Drugs for Treatment of Prostate Cancer Revenue Share List of Key Manufacturers 2010 to 2015 33 Table Russia Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 2016 34 Table Brazil Market Drugs for Treatment of Prostate Cancer Sales List of Key Manufacturers 2010 to 2015 34 Table Brazil Market Drugs for Treatment of Prostate Cancer Sales Share List of Key Manufacturers 2010 to 2015 35 Table Brazil Market Drugs for Treatment of Prostate Cancer Revenue List of Key Manufacturers 2010 to 2015 35 Table Brazil Market Drugs for Treatment of Prostate Cancer Revenue Share List of Key Manufacturers 2010 to 2015 36 Table Brazil Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 2016 36 Table Japan Market Drugs for Treatment of Prostate Cancer Sales List of Key Manufacturers 2010 to 2015 37 Table Japan Market Drugs for Treatment of Prostate Cancer Sales Share List of Key Manufacturers 2010 to 2015 37 Table Japan Market Drugs for Treatment of Prostate Cancer Revenue List of Key Manufacturers 2010 to 2015 38 Table Japan Market Drugs for Treatment of Prostate Cancer Revenue Share List of Key Manufacturers 2010 to 2015 39 Table Japan Drugs for Treatment of Prostate Cancer Average Price List of Key Manufacturers 2015 to 2016 39 Table China Sales of Each Type 2010 to 2015 40 Table China Sales Market Share of Each Type 2010 to 2015 40 Table China Sales Growth Rate of Each Type 2015 to 2016 40 Table China Revenue of Each Type 2015 to 2016 41 Table China Revenue Market Share of Each Type 2015 to 2016 41 Table China Revenue of Each Type 2015 to 2016 41 Table China Revenue Market Share of Each Type 2015 to 2016 42 Table Global Sales of Each Type 2015 to 2016 42 Table Russia Sales Market Share of Each Type 2015 to 2016 42 Table Global Sales Growth Rate of Each Type 2015 to 2016 42 Table Global Revenue of Each Type 2015 to 2016 43 Table Russia Revenue Market Share of Each Type 2015 to 2016 43 Table Russia Revenue of Each Type 2015 to 2016 43 Table Russia Revenue Market Share of Each Type 2015 to 2016 44 Table Brazil Sales of Each Type 2015 to 2016 44 Table Brazil Sales Market Share of Each Type 2015 to 2016 44 Table Brazil Sales Growth Rate of Each Type 2015 to 2016 45 Table Brazil Revenue of Each Type 2015 to 2016 45 Table Brazil Revenue Market Share of Each Type 2015 to 2016 45 Table Brazil Revenue of Each Type 2015 to 2016 45 Table Brazil Revenue Market Share of Each Type 2015 to 2016 46 Table Japan Sales of Each Type 2015 to 2016 46 Table Japan Sales Market Share of Each Type 2015 to 2016 46 Table Japan Sales Growth Rate of Each Type 2015 to 2016 47 Table Japan Revenue of Each Type 2015 to 2016 47 Table Japan Revenue Market Share of Each Type 2015 to 2016 47 Table Japan Revenue of Each Type 2015 to 2016 47 Table Japan Revenue Market Share of Each Type 2015 to 2016 48 Table Sales and Forecast of Drugs for Treatment of Prostate Cancer by Regions 2016-2021 49 Figure Sales Growth Rate Forecast of Drugs for Treatment of Prostate Cancer by Regions 2016 to 2021 50 Table Key Raw Materials for Triptorelin 51 Table Price Forecast of Key Raw Materials for Triptorelin 51 Table Key Raw Materials for Leuprorelin 52 Table Price Forecast of Key Raw Materials for Leuprorelin 52 Table Key Raw Materials for Flutamide Tablets 52 Table Price Forecast of Key Raw Materials for Flutamide Tablets 53 Table Key Raw Materials for Goserelin 53 Table Price Forecast of Key Raw Materials for Goserelin 53 Table Key Raw Materials for Bicalutamide Tablets 54 Table Price Forecast of Key Raw Materials for Bicalutamide Tablets 54 Table Key Raw Materials for Bicalutamide Capsules 55 Table Price Forecast of Key Raw Materials for Bicalutamide Capsules 55 Table Key Raw Materials for Estramustine Phosphate Capsules 55 Table Price Forecast of Key Raw Materials for Estramustine Phosphate Capsules 56 Table Key Raw Materials for Mitoxantrone 56 Table Price Forecast of Key Raw Materials for Mitoxantrone 57 Table Key Raw Materials for Zytiga 57 Table Price Forecast of Key Raw Materials for Zytiga 57 Table Key Raw Materials for Xtandi 58 Table Price Forecast of Key Raw Materials for Zytiga 58 Table Applications of Triptorelin 58 Table Applications of Leuprorelin 59 Table Applications of Flutamide Tablets 59 Table Applications of Goserelin 59 Table Applications of Bicalutamide Tablets 59 Table Applications of Bicalutamide Capsules 60 Table Applications of Estramustine Phosphate Capsules 60 Table Applications of Mitoxantrone 60 Table Applications of Zytiga 61 Table Applications of Xtandi 61 Table IPSEN Basic Information List 62 Table Specification, Price, Sales Value (China, Russia, Brazil and Japan) and Market Share of IPSEN 62 Table Sales Value, Gross Margin and Growth rate of IPSEN in China 62 Figure Product Sales Value, Growth rate of IPSEN in China 63 Table Sales Value, Gross Margin and Growth rate of IPSEN in Russia 63 Figure Product Sales Value, Growth rate of IPSEN in Russia 63 Table Sales Value, Gross Margin and Growth rate of IPSEN in Brazil 63 Figure Product Sales Value, Growth rate of IPSEN in Brazil 63 Table Sales Value, Gross Margin and Growth rate of IPSEN in Japan 63 Figure Product Sales Value, Growth rate of IPSEN in Japan 64 Table Ferring Pharmaceuticals Basic Information List 64 Table Specification, Price, Sales Value (China, Russia, Brazil and Japan) and Market Share of Ferring Pharmaceuticals 64 Table Sales Value, Gross Margin and Growth rate of Ferring Pharmaceuticals in China 65 Figure Product Sales Value, Growth rate of Ferring Pharmaceuticals in China 65 Table Sales Value, Gross Margin and Growth rate of Ferring Pharmaceuticals in Russia 65 Figure Product Sales Value, Growth rate of Ferring Pharmaceuticals in Russia 65 Table Sales Value, Gross Margin and Growth rate of Ferring Pharmaceuticals in Brazil 65 Figure Product Sales Value, Growth rate of Ferring Pharmaceuticals in Brazil 65 Table Sales Value, Gross Margin and Growth rate of Ferring Pharmaceuticals in Japan 66 Figure Product Sales Value, Growth rate of Ferring Pharmaceuticals in Japan 66 Table Chengdu Tiantaishan pharmaceutical Basic Information List 66 Table Specification, Price, Sales Value and Market Share of Chengdu Tiantaishan pharmaceutical in China 67 Table Sales Value, Gross Margin and Growth rate of Chengdu Tiantaishan pharmaceutical in China 67 Figure Product Sales Value, Growth rate of Chengdu Tiantaishan pharmaceutical in China 67 Table GeneScience Pharmaceuticals Basic Information List 67 Table Specification, Price, Sales Value and Market Share of GeneScience Pharmaceuticals in China 68 Table Sales Value, Gross Margin and Growth rate of GeneScience Pharmaceuticals in China 68 Figure Product Sales Value, Growth rate of GeneScience Pharmaceuticals in China 68 Table Takeda Pharmaceutical Company Limited Basic Information List 69 Table Specification, Price, Sales Value (China, Russia, Brazil and Japan) and Market Share of Takeda Pharmaceutical Company Limited 69 Table Sales Value, Gross Margin and Growth rate of Takeda Pharmaceutical Company Limited in China 69 Figure Product Sales Value, Growth rate of Takeda Pharmaceutical Company Limited in China 70 Table Sales Value, Gross Margin and Growth rate of Takeda Pharmaceutical Company Limited in Russia 70 Figure Product Sales Value, Growth rate of Takeda Pharmaceutical Company Limited in Russia 70 Table Sales Value, Gross Margin and Growth rate of Takeda Pharmaceutical Company Limited in Brazil 70 Figure Product Sales Value, Growth rate of Takeda Pharmaceutical Company Limited in Brazil 70 Table Sales Value, Gross Margin and Growth rate of Takeda Pharmaceutical Company Limited in Japan 70 Figure Product Sales Value, Growth rate of Takeda Pharmaceutical Company Limited in Japan 71 Table Beijing Biote Pharmaceutical Basic Information List 71 Table Specification, Price, Sales Value and Market Share of Beijing Biote Pharmaceutical in China 71 Table Sales Value, Gross Margin and Growth rate of Beijing Biote Pharmaceutical in China 72 Figure Product Sales Value, Growth rate of Beijing Biote Pharmaceutical in China 72 Table Livzon Pharmaceutical Group Basic Information List 72 Table Specification, Price, Sales Value and Market Share of Livzon Pharmaceutical Group in China 73 Table Sales Value, Gross Margin and Growth rate of Livzon Pharmaceutical Group in China 73 Figure Product Sales Value, Growth rate of Livzon Pharmaceutical Group in China 73 Table Schering-Plough Canada Basic Information List 73 Table Specification, Price, Sales Value (China, Russia, Brazil and Japan) and Market Share of Schering-Plough Canada 74 Table Sales Value, Gross Margin and Growth rate of Schering-Plough Canada in China 74 Figure Product Sales Value, Growth rate of Schering-Plough Canada in China 74 Table Sales Value, Gross Margin and Growth rate of Schering-Plough Canada in Russia 74 Figure Product Sales Value, Growth rate of Schering-Plough Canada in Russia 75 Table Sales Value, Gross Margin and Growth rate of Schering-Plough Canada in Brazil 75 Figure Product Sales Value, Growth rate of Schering-Plough Canada in Brazil 75 Table Sales Value, Gross Margin and Growth rate of Schering-Plough Canada in Japan 75 Figure Product Sales Value, Growth rate of Schering-Plough Canada in Japan 75 Table JiangSu TASLY DI YI Pharmaceutical Basic Information List 76 Table Specification, Price, Sales Value and Market Share of JiangSu TASLY DI YI Pharmaceutical in China 76 Table Sales Value, Gross Margin and Growth rate of JiangSu TASLY DI YI Pharmaceutical in China 76 Figure Product Sales Value, Growth rate of JiangSu TASLY DI YI Pharmaceutical in China 77 Table Shanghai Fudan Fuhua Pharmaceutical Basic Information List 77 Table Specification, Price, Sales Value and Market Share of Shanghai Fudan Fuhua Pharmaceutical in China 77 Table Sales Value, Gross Margin and Growth rate of Shanghai Fudan Fuhua Pharmaceutical in China 78 Figure Product Sales Value, Growth rate of Shanghai Fudan Fuhua Pharmaceutical in China 78 Table S.C.SINDAN-PHARMA S.R.L. Basic Information List 78 Table Specification, Price, Sales Value (China, Russia, Brazil and Japan) and Market Share of S.C.SINDAN-PHARMA S.R.L. 79 Table Sales Value, Gross Margin and Growth rate of S.C.SINDAN-PHARMA S.R.L. in China 79 Figure Product Sales Value, Growth rate of S.C.SINDAN-PHARMA S.R.L. in China 79 Table Sales Value, Gross Margin and Growth rate of S.C.SINDAN-PHARMA S.R.L. in Russia 79 Figure Product Sales Value, Growth rate of S.C.SINDAN-PHARMA S.R.L. in Russia 79 Table Sales Value, Gross Margin and Growth rate of S.C.SINDAN-PHARMA S.R.L. in Brazil 80 Figure Product Sales Value, Growth rate of S.C.SINDAN-PHARMA S.R.L. in Brazil 80 Table Sales Value, Gross Margin and Growth rate of S.C.SINDAN-PHARMA S.R.L. in Japan 80 Figure Product Sales Value, Growth rate of S.C.SINDAN-PHARMA S.R.L. in Japan 80 Table AstraZeneca Basic Information List 80 Table Specification, Price, Sales Value (China, Russia, Brazil and Japan)and Market Share of Pfizer 81 Table Sales Value, Gross Margin and Growth rate of AstraZeneca in China 81 Figure Product Sales Value, Growth rate of AstraZeneca in China 81 Table Sales Value, Gross Margin and Growth rate of AstraZeneca in Russia 81 Figure Product Sales Value, Growth rate of AstraZeneca in Russia 82 Table Sales Value, Gross Margin and Growth rate of AstraZeneca in Brazil 82 Figure Product Sales Value, Growth rate of AstraZeneca in Brazil 82 Table Sales Value, Gross Margin and Growth rate of AstraZeneca in Japan 82 Figure Product Sales Value, Growth rate of AstraZeneca in Japan 82 Table Corden Pharma GmbH Basic Information List 83 Table Specification, Price, Sales Value(China, Russia, Brazil and Japan)and Market Share of Corden Pharma GmbH 83 Table Sales Value, Gross Margin and Growth rate of Corden Pharma GmbH in China 83 Figure Product Sales Value, Growth rate of Corden Pharma GmbH in China 84 Table Sales Value, Gross Margin and Growth rate of Corden Pharma GmbH in Russia 84 Figure Product Sales Value, Growth rate of Corden Pharma GmbH in Russia 84 Table Sales Value, Gross Margin and Growth rate of Corden Pharma GmbH in Brazil 84 Figure Product Sales Value, Growth rate of Corden Pharma GmbH in Brazil 84 Table Sales Value, Gross Margin and Growth rate of Corden Pharma GmbH in Japan 84 Figure Product Sales Value, Growth rate of Corden Pharma GmbH in Japan 85 Table Shanghai Zhaohui Pharmaceutical Basic Information List 85 Table Specification, Price, Sales Value and Market Share of Shanghai Zhaohui Pharmaceutical in China 85 Table Sales Value, Gross Margin and Growth rate of Shanghai Zhaohui Pharmaceutical in China 86 Figure Product Sales Value, Growth rate of Shanghai Zhaohui Pharmaceutical in China 86 Table HISUN Pharmaceutical Basic Information List 86 Table Specification, Price, Sales Value and Market Share of HISUN Pharmaceutical in China 87 Table Sales Value, Gross Margin and Growth rate of HISUN Pharmaceutical in China 87 Figure Product Sales Value (M USD), Growth rate of HISUN Pharmaceutical in China 87 Table Shanxi Zhendong Pharmaceutical Basic Information List 87 Table Specification, Price, Sales Value and Market Share of Shanxi Zhendong Pharmaceutical in China 88 Table Sales Value, Gross Margin and Growth rate of Shanxi Zhendong Pharmaceutical in China 88 Figure Product Sales Value, Growth rate of Shanxi Zhendong Pharmaceutical in China 88 Table Pfizer Basic Information List 89 Table Specification, Price, Sales Value (China, Russia, Brazil and Japan)and Market Share of Pfizer 89 Table Sales Value, Gross Margin and Growth rate of Pfizer in China 89 Figure Product Sales Value, Growth rate of Pfizer in China 90 Table Sales Value, Gross Margin and Growth rate of Pfizer in Russia 90 Figure Product Sales Value, Growth rate of Pfizer in Russia 90 Table Sales Value, Gross Margin and Growth rate of Pfizer in Brazil 90 Figure Product Sales Value, Growth rate of Pfizer in Brazil 90 Table Sales Value, Gross Margin and Growth rate of Pfizer in Japan 90 Figure Product Sales Value, Growth rate of Pfizer in Japan 90 Table Sichuan sunnyhope pharmaceutical Basic Information List 91 Table Specification, Price, Sales Value and Market Share of Sichuan sunnyhope pharmaceutical in China 91 Table Sales Value, Gross Margin and Growth rate of Sichuan sunnyhope pharmaceutical in China 91 Figure Product Sales Value, Growth rate of Sichuan sunnyhope pharmaceutical in China 92 Table Luoxin Group Basic Information List 92 Table Specification, Price, Sales Value and Market Share of Luoxin Group in China 92 Table Sales Value, Gross Margin and Growth rate of Luoxin Group in China 93 Figure Product Sales Value, Growth rate of Luoxin Group in China 93 Table Jiangsu Aosaikang Pharmaceutical Group Basic Information List 93 Table Specification, Price, Sales Value and Market Share of Jiangsu Aosaikang Pharmaceutical in China 94 Table Sales Value, Gross Margin and Growth rate of Jiangsu Aosaikang Pharmaceutical in China 94 Figure Product Sales Value, Growth rate of Jiangsu Aosaikang Pharmaceutical 94 Table Jiangsu Aosaikang Pharmaceutical Group Basic Information List 94 Table Specification, Price, Sales Value and Market Share of JIANG SU HENG RUI MEDICINE in China 95 Table Sales Value, Gross Margin and Growth rate of JIANG SU HENG RUI MEDICINE China 95 Figure Product Sales Value, Growth rate of JIANG SU HENG RUI MEDICINE in China 95 Table Johnson Basic Information List 96 Table Specification, Price, Sales Value and Market Share of Johnson in Japan 96 Table Sales Value, Gross Margin and Growth rate of Johnson in Japan 96 Figure Product Sales Value, Growth rate of Johnson in Japan 96 Table Sales Value, Gross Margin and Growth rate of Johnson in Russia 97 Figure Product Sales Value, Growth rate of Johnson in Russia 97 Table Astellas Basic Information List 97 Table Specification, Price, Sales Value and Market Share of Astellas in Japan 97 Table Sales Value, Gross Margin and Growth rate of Astellas in Japan 98 Figure Product Sales Value, Growth rate of Astellas in Japan 98



To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global automotive coatings market size is likely to be valued at USD 27.7 billion by 2022; as per a new research report by Radiant Insights, Inc. Vehicle aesthetics, UV radiation and temperature variation protection and enhance durability are certain

Read More...

Global sorbitol market size is anticipated to be reach USD 3.99 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing consumer perception towards product benefits derived from natural ingredients is expected to drive the dem

Read More...

Global contact lenses market size is estimated to reach USD 12.5 billion by 2020, according to a new industry report by Radiant Insights, Inc. Growing number of ophthalmic disorder observed in global population especially children is likely to drive

Read More...

Global outsourced customer care services market is projected to reach USD 84.7 billion by 2020, as per a new research report by Radiant Insights, Inc. Swelling need for interaction through non-voice channels is estimated to boost global demand over t

Read More...

Global automotive collision repair market is expected to be valued at USD 196.97 billion by 2020, as per a new research report by Radiant Insights, Inc. The industry is expected to witness significant growth owing to increasing number of on-road vehi

Read More...
Choose License Type
Single User - US $3650
Multi User - US $6300
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify